Oncoethix GmbH
Records under this name other than patents Oncoethix GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Oncoethix GmbH
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,968,619 | Method of treating triple-negative breast cancer using thienotriazolodiazepine compounds Lapsed on the fee record Ended May 15, 2022 · From the USPTO record | Lapsed on the fee record | Ended May 15, 2022 | From the USPTO record |
| US 9,968,620 | Methods of treating lymphoma using thienotriazolodiazepine compounds Lapsed on the fee record Ended May 15, 2022 · From the USPTO record | Lapsed on the fee record | Ended May 15, 2022 | From the USPTO record |
| US 9,956,228 | Method of treating acute myeloid leukemia and/or acute lymphoblastic leukemia using thienotriazolodiazepine compounds Lapsed on the fee record Ended May 1, 2022 · From the USPTO record | Lapsed on the fee record | Ended May 1, 2022 | From the USPTO record |
| US 9,901,583 | Method of treating non-small cell lung cancer and/or small cell lung cancer using thienotriazolodiazepine compounds Lapsed on the fee record Ended Feb 27, 2022 · From the USPTO record | Lapsed on the fee record | Ended Feb 27, 2022 | From the USPTO record |
| US 9,820,992 | Method of treating non-small-cell lung cancer using pharmaceutical formulation containing thienotriazolodiazepine compounds Lapsed on the fee record Ended Nov 21, 2021 · From the USPTO record | Lapsed on the fee record | Ended Nov 21, 2021 | From the USPTO record |
| US 9,795,612 | Pharmaceutical formulation containing thienotriazolodiazepine compounds Lapsed on the fee record Ended Oct 24, 2021 · From the USPTO record | Lapsed on the fee record | Ended Oct 24, 2021 | From the USPTO record |
| US 9,757,385 | Method of treating leukemia using pharmaceutical formulation containing thienotriazolodiazepine compounds Lapsed on the fee record Ended Sep 12, 2021 · From the USPTO record | Lapsed on the fee record | Ended Sep 12, 2021 | From the USPTO record |